Skip to menu Skip to content Skip to footer
Associate Professor

John Yaxley

Email: 

Overview

Availability

Associate Professor John Yaxley is:
Available for supervision

Works

Search Professor John Yaxley’s works on UQ eSpace

168 works between 1998 and 2024

1 - 20 of 168 works

2024

Journal Article

The ‘Prostate Embolisation AS first-line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH

Brown, Nicholas, Kiosoglous, Anthony, Castree, Stephanie, Firouzmand, Sepinoud, McBean, Rhiannon, Walker, Duncan G., Wallace, Sean, Kua, Boon, Gianduzzo, Troy, Esler, Rachel C., Campbell, Peter, Schoeman, Joseph and Yaxley, John (2024). The ‘Prostate Embolisation AS first-line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH. BJU International, 134 (S2), 38-46. doi: 10.1111/bju.16479

The ‘Prostate Embolisation AS first-line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH

2024

Journal Article

The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort

Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Pelecanos, Anita, Gan, Chun Loo, Goh, Jeffrey C., Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2024). The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort. European Urology Focus, 10 (5), 770-778. doi: 10.1016/j.euf.2023.12.004

The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort

2024

Journal Article

Does a retzius-sparing surgical technique improve urinary continence recovery after a robot-assisted laparoscopic radical prostatectomy: results of a systematic review and meta-analysis of comparative studies

Yaxley, John William and Gianduzzo, Troy (2024). Does a retzius-sparing surgical technique improve urinary continence recovery after a robot-assisted laparoscopic radical prostatectomy: results of a systematic review and meta-analysis of comparative studies. Prostate Cancer and Prostatic Diseases. doi: 10.1038/s41391-024-00881-5

Does a retzius-sparing surgical technique improve urinary continence recovery after a robot-assisted laparoscopic radical prostatectomy: results of a systematic review and meta-analysis of comparative studies

2024

Journal Article

Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care

Lindsay, Daniel, Schofield, Penelope, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Collins, Louisa G. (2024). Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care. European Urology Oncology. doi: 10.1016/j.euo.2024.08.005

Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care

2024

Journal Article

Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis “PCAN-23-0763R”

Yaxley, J. W. and Fitzgerald, B. (2024). Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis “PCAN-23-0763R”. Prostate Cancer and Prostatic Diseases. doi: 10.1038/s41391-024-00873-5

Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis “PCAN-23-0763R”

2024

Journal Article

Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?

Roberts, Matthew J., Yaxley, John W., Stranne, Johan, van Oort, Inge M. and Tilki, Derya (2024). Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?. Prostate Cancer and Prostatic Diseases, 1-3. doi: 10.1038/s41391-024-00821-3

Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?

2024

Journal Article

The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis

Lindsay, Daniel, Schofield, Penelope, Nabukalu, Doreen, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Gordon, Louisa G. (2024). The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis. Australian Health Review, 48 (2), 172-181. doi: 10.1071/ah23231

The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis

2024

Journal Article

The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study

Franklin, Anthony, Gianduzzo, Troy, Kua, Boon, Wong, David, McEwan, Louise, Walters, James, Esler, Rachel, Roberts, Matthew J., Coughlin, Geoff and Yaxley, John W. (2024). The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study. Asian Journal of Urology, 11 (1), 33-41. doi: 10.1016/j.ajur.2023.01.007

The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study

2023

Journal Article

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography

Vis, André N., Meijer, Dennie, Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., Heymans, Martijn W., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Stricker, Phillip, Haynes, Anne-Maree, Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and van Leeuwen, Pim J. (2023). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. European Urology Oncology, 6 (6), 553-563. doi: 10.1016/j.euo.2023.03.010

Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography

2023

Journal Article

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management

Pathmanathan, Shivanshan, Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dhiantravan, Nattakorn, Esler, Rachel, Dunglison, Nigel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A., Goh, Jeffrey C., Gan, Chun Loo and Roberts, Matthew J. (2023). Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management. European Journal of Nuclear Medicine and Molecular Imaging, 51 (1), 295-303. doi: 10.1007/s00259-023-06380-4

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management

2023

Journal Article

Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework

Patel, Nishal, Mehawed, Georges, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John, Chung, Eric, Tse, Vincent and Roberts, Matthew J. (2023). Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework. Urology, 178, 1-8. doi: 10.1016/j.urology.2023.05.002

Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework

2023

Journal Article

Clinicopathologic significance of anterior prostate cancer: comparison with posterior prostate cancer in the era of multiparametric magnetic resonance imaging

Samaratunga, Hemamali, Egevad, Lars, Yaxley, John W., Johannsen, Shulammite, Le Fevre, Ian K., Perry-Keene, Joanna L., Gianduzzo, Troy, Chabert, Charles, Coughlin, Gregory, Parkinson, Robert, Kua, Boon, Yaxley, William and Delahunt, Brett (2023). Clinicopathologic significance of anterior prostate cancer: comparison with posterior prostate cancer in the era of multiparametric magnetic resonance imaging. American Journal of Surgical Pathology, 47 (6), 701-708. doi: 10.1097/pas.0000000000002042

Clinicopathologic significance of anterior prostate cancer: comparison with posterior prostate cancer in the era of multiparametric magnetic resonance imaging

2023

Journal Article

Focal irreversible electroporation for treatment of primary and radio-recurrent prostate cancer – the evidence is mounting!

Yaxley, John W. (2023). Focal irreversible electroporation for treatment of primary and radio-recurrent prostate cancer – the evidence is mounting!. BJU International, 131 (S4), 32-33. doi: 10.1111/bju.15987

Focal irreversible electroporation for treatment of primary and radio-recurrent prostate cancer – the evidence is mounting!

2022

Journal Article

LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia

Samaratunga, Hemamali, Egevad, Lars, Thunders, Michelle, Iczskowski, Kenneth A., van der Kwast, Theodorus, Kristiansen, Glen, Pan, Chin-Chen, Leite, Katia R.M., Evans, Andrew, Clouston, David, Kenwright, Diane N., Bethwaite, Peter B., Malone, Greg, Wood, Simon, Yaxley, John W. and Delahunt, Brett (2022). LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia. Pathology, 54 (7), 842-847. doi: 10.1016/j.pathol.2022.09.002

LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia

2022

Journal Article

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

Ong, Sean, Chen, Kenneth, Grummet, Jeremy, Yaxley, John, Scheltema, Matthijs J., Stricker, Phillip, Tay, Kae Jack and Lawrentschuk, Nathan (2022). Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?. BJU International, 131 (1), 20-31. doi: 10.1111/bju.15883

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?

2022

Journal Article

Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)

Tariq, Arsalan, McGeorge, Stephen, Pearce, Adam, Rhee, Handoo, Wood, Simon, Kyle, Samuel, Marsh, Philip, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Westera, Jurjen, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2022). Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT). Urologic Oncology: Seminars and Original Investigations, 40 (6), 276.e1-276.e9. doi: 10.1016/j.urolonc.2022.03.007

Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT)

2022

Journal Article

Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy

Yaxley, William, Delahunt, Brett, Yaxley, John, Thunders, Michelle C., Kenwright, Diane N., Egevad, Lars and Samaratunga, Hemamali (2022). Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy. Pathology, 54 (6), 694-699. doi: 10.1016/j.pathol.2022.02.009

Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy

2022

Journal Article

Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study

Yaxley, William John, Gianduzzo, Troy, Kua, Boon, Oxford, Rachel and Yaxley, John William (2022). Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study. Investigative and Clinical Urology, 63 (3), 285-293. doi: 10.4111/icu.20210472

Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study

2022

Journal Article

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

Roberts, Matthew J., Morton, Andrew, Papa, Nathan, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Coughlin, Geoffrey, Gianduzzo, Troy, Kua, Boon, McEwan, Louise, Wong, David, Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Brown, Nicholas, Parkinson, Robert, Emmett, Louise and Yaxley, John W. (2022). Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging, 49 (9), 3289-3294. doi: 10.1007/s00259-022-05756-2

Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

2022

Journal Article

Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer

Raveenthiran, S., Yaxley, W. J., Franklin, T., Coughlin, G., Roberts, M., Gianduzzo, T., Kua, B., Samaratunga, H., Delahunt, B., Egevad, L., Wong, D., McEwan, L., Brown, N., Parkinson, R., Esler, R. and Yaxley, J. W. (2022). Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer. Journal of Urology, 207 (3), 573-580. doi: 10.1097/JU.0000000000002293

Findings in 1,123 men with preoperative 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography and multiparametric magnetic resonance imaging compared to totally embedded radical prostatectomy histopathology: Implications for the diagnosis and management of prostate cancer

Supervision

Availability

Associate Professor John Yaxley is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Completed supervision

Media

Enquiries

For media enquiries about Associate Professor John Yaxley's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au